4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-13-001321
CEO gave up 36,190 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEWIS JONATHAN CEO | 2012-12-31 | Shares withheld for taxes | −14,715 | $4.21 | $61,950 | 546,251 | D |
| LEWIS JONATHAN CEO | 2012-12-31 | Shares withheld for taxes | −21,475 | $4.16 | $89,336 | 524,776 | D |
| Derivatives | |||||||
| LEWIS JONATHAN CEO | 2012-12-31 | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | D | ||
Loading xslF345X03/doc4.xml…